InflaRx N.V. - stock earnings
IFRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -7.9 million USD | 64368 USD |
| 2023Q2 | -8.9 million USD | ? USD |
| 2023Q1 | -13.3 million USD | ? USD |
| 2022Q4 | -9.4 million USD | ? USD |
| 2022Q3 | -6.9 million USD | ? USD |
| 2022Q2 | 2.1 million USD | ? USD |
| 2022Q1 | -14.8 million USD | ? USD |
| 2021Q4 | -14.4 million USD | ? USD |
| 2021Q3 | -14.0 million USD | ? USD |
| 2021Q2 | -17.5 million USD | ? USD |
| 2021Q1 | -7.2 million USD | ? USD |
| 2020Q4 | -10.8 million USD | ? USD |
| 2020Q3 | -8.0 million USD | ? USD |
| 2020Q2 | -11.3 million USD | ? USD |
| 2020Q1 | -15.1 million USD | ? USD |
| 2019Q4 | -15.3 million USD | ? USD |
| 2019Q3 | -15.9 million USD | ? USD |
| 2019Q2 | -17.4 million USD | ? USD |
| 2019Q1 | -11.0 million USD | ? USD |
| 2018Q4 | -11.8 million USD | ? USD |
| 2018Q3 | -7.9 million USD | ? USD |
| 2018Q2 | -2.8 million USD | ? USD |
| 2018Q1 | -12.7 million USD | ? USD |
| 2017Q4 | -14.0 million USD | 275860 USD |
| 2017Q3 | -4.8 million USD | ? USD |
| 2017Q2 | -5.3 million USD | ? USD |
| 2017Q1 | -4.1 million USD | ? USD |
| 2016Q4 | -4.6 million USD | ? USD |
| 2016Q3 | -2.4 million USD | ? USD |
| 2016Q2 | -1.2 million USD | ? USD |
| 2015Q4 | -5.4 million USD | ? USD |
IFRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -38.4 million USD | 67215 USD |
| 2022 | -29.0 million USD | ? USD |
| 2021 | -51.9 million USD | ? USD |
| 2020 | -41.4 million USD | ? USD |
| 2019 | -55.7 million USD | ? USD |
| 2018 | -34.1 million USD | ? USD |
| 2017 | -28.9 million USD | 275860 USD |
| 2016 | -9.4 million USD | ? USD |
| 2015 | -5.4 million USD | ? USD |
IFRX
Price: $1.38
52 week price:
Earnings Per Share: -0.84 USD
P/E Ratio: -2.19
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 38219
Market Capitalization: 88.3 million